RFXANK: A Novel Immune-Related Biomarker for Hepatocellular Carcinoma

holds promise as a novel biomarker for diagnostic assessment and a potential therapeutic target for HCC patients.

Authors

Institutions

Publication Details

Journal
Genes
Published
2026-03-31
DOI
https://doi.org/10.3390/genes17040406
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RFXANK: A Novel Immune-Related Biomarker for Hepatocellular Carcinoma

Lv Tian, Taimei Qu
Genes
Ferroptosis and cancer prognosis
article

RFXANK: A Novel Immune-Related Biomarker for Hepatocellular Carcinoma

Lv Tian, Taimei Qu
article en

Abstract

holds promise as a novel biomarker for diagnostic assessment and a potential therapeutic target for HCC patients.

GenesVol. 17(4)
University of Electronic Science and Technology of China (CN), Chinese PLA General Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 37%
Ferroptosis and cancer prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

RFXANK: A Novel Immune-Related Biomarker for Hepatocellular Carcinoma — Lv Tian, Taimei Qu · Genes (2026) | TGRS Research Map | TGRS